Skip to main content

Search

9 result(s) for 'author#Uwe Schirmer' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. Following publication of the original article [1], we have been alerted to errors in Figs. 2 and 8. In Fig. 2B, the GAPDH loading control for Hec1A cells is shown twice in error (in Fig. 2B and Fig. 2C). In Fi...

    Authors: Uwe Schirmer, Heidi Fiegl, Marco Pfeifer, Alain G. Zeimet, Elisabeth Müller-Holzner, Peter K. Bode, Verena Tischler and Peter Altevogt
    Citation: BMC Cancer 2018 18:1047

    The original article was published in BMC Cancer 2013 13:156

  2. L1CAM was originally identified as an adhesion molecule involved in neural development. In many human carcinomas L1CAM is over-expressed and is associated with a bad prognosis. We previously reported that L1CA...

    Authors: Uwe Schirmer, Heidi Fiegl, Marco Pfeifer, Alain G Zeimet, Elisabeth Müller-Holzner, Peter K Bode, Verena Tischler and Peter Altevogt
    Citation: BMC Cancer 2013 13:156

    The Correction to this article has been published in BMC Cancer 2018 18:1047

  3. The L1 cell adhesion molecule (L1CAM) was originally identified as a neural adhesion molecule involved in axon guidance. In many human epithelial carcinomas L1CAM is overexpressed and thereby augments cell mot...

    Authors: Marco Pfeifer, Uwe Schirmer, Claudia Geismann, Heiner Schäfer, Susanne Sebens and Peter Altevogt
    Citation: BMC Molecular Biology 2010 11:64
  4. The L1 cell adhesion molecule (L1CAM) is potentially involved in epithelial-mesenchymal transition (EMT). EMT marker expression is of prognostic significance in non-small cell lung cancer (NSCLC). The relevanc...

    Authors: Verena Tischler, Marco Pfeifer, Silke Hausladen, Uwe Schirmer, Anne-Katrine Bonde, Glen Kristiansen, Martin L Sos, Walter Weder, Holger Moch, Peter Altevogt and Alex Soltermann
    Citation: Molecular Cancer 2011 10:127
  5. Breast cancer is a heterogeneous disease displaying distinct molecular features and clinical outcome. The molecular profile of triple-negative breast cancers (TNBCs) overlaps with that of basal-like breast can...

    Authors: Kai Doberstein, Karin Milde-Langosch, Niko P Bretz, Uwe Schirmer, Ayelet Harari, Isabell Witzel, Alon Ben-Arie, Michael Hubalek, Elisabeth Müller-Holzner, Susanne Reinold, Alain G Zeimet, Peter Altevogt and Mina Fogel
    Citation: BMC Cancer 2014 14:958
  6. Acute cardiovascular dysfunction occurs perioperatively in more than 20% of cardiosurgical patients, yet current acute heart failure (HF) classification is not applicable to this period. Indicators of major pe...

    Authors: Alexandre Mebazaa, Antonis A Pitsis, Alain Rudiger, Wolfgang Toller, Dan Longrois, Sven-Erik Ricksten, Ilona Bobek, Stefan De Hert, Georg Wieselthaler, Uwe Schirmer, Ludwig K von Segesser, Michael Sander, Don Poldermans, Marco Ranucci, Peter CJ Karpati, Patrick Wouters…
    Citation: Critical Care 2010 14:201
  7. Non-small cell lung cancer (NSCLC) is the most common cause of cancer-related deaths worldwide and is primarily treated with radiation, surgery, and platinum-based drugs like cisplatin and carboplatin. The maj...

    Authors: Sabrina Grasse, Matthias Lienhard, Steffen Frese, Martin Kerick, Anne Steinbach, Christina Grimm, Michelle Hussong, Jana Rolff, Michael Becker, Felix Dreher, Uwe Schirmer, Stefan Boerno, Anna Ramisch, Gunda Leschber, Bernd Timmermann, Christian Grohé…
    Citation: Genome Medicine 2018 10:55
  8. Central venous saturation (ScvO2) monitoring has been suggested to address the issue of adequate cardiocirculatory function in the context of cardiac surgery. The aim of this study was to determine the impact of ...

    Authors: Felix Balzer, Michael Sander, Mark Simon, Claudia Spies, Marit Habicher, Sascha Treskatsch, Viktor Mezger, Uwe Schirmer, Matthias Heringlake, Klaus-Dieter Wernecke, Herko Grubitzsch and Christian von Heymann
    Citation: Critical Care 2015 19:168